CLM (n=20*) | Control (n=20) | p Value | |
---|---|---|---|
Use of asthma medication | |||
Never | 10 | 18 | 0.007 |
Previously (discontinued medication) | 5 | 0 | 0.02 |
Currently | 3 | 1 | 0.3 |
Self-reported dyspnoea during exercise | 11 | 1 | <0.001 |
Laryngeal characteristics at rest* | |||
Prominent arytaenoids | 14 | 8 | 0.06 |
Prominent ω-shaped epiglottis | 11 | 1 | <0.001 |
Both levels | 9 | 0 | 0.001 |
Laryngeal characteristics† | |||
During exercise; that is, Maat-D 2 or 3 | 14 | 2 | <0.001 |
Except p values the figures are numbers with the characteristic in question. p Values are calculated using Fisher's exact test.
*Background information was missing for two patients in the CLM group.
†Results from laryngoscopy (standardised visual score according to Maat et al30).